HomeCompareGECFF vs MRK

GECFF vs MRK: Dividend Comparison 2026

GECFF yields 8.27% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $29.7K in total portfolio value· pulled ahead in Year 4
10 years
GECFF
GECFF
● Live price
8.27%
Share price
$77.83
Annual div
$6.44
5Y div CAGR
-12.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.0K
Annual income
$302.38
Full GECFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GECFF vs MRK

📍 MRK pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGECFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GECFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GECFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GECFF
Annual income on $10K today (after 15% tax)
$702.89/yr
After 10yr DRIP, annual income (after tax)
$257.02/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,071.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GECFF + MRK for your $10,000?

GECFF: 50%MRK: 50%
100% MRK50/50100% GECFF
Portfolio after 10yr
$41.9K
Annual income
$5,050.26/yr
Blended yield
12.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GECFF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.6
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GECFF buys
0
MRK buys
0
No recent congressional trades found for GECFF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGECFFMRK
Forward yield8.27%2.76%
Annual dividend / share$6.44$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-12.3%32.7%
Portfolio after 10y$27.0K$56.8K
Annual income after 10y$302.38$9,798.13
Total dividends collected$5.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: GECFF vs MRK ($10,000, DRIP)

YearGECFF PortfolioGECFF Income/yrMRK PortfolioMRK Income/yrGap
1$11,425$725.22$11,206$366.19+$219.00GECFF
2$12,904$679.12$12,650$502.35+$254.00GECFF
3$14,436$628.68$14,407$694.19+$29.00GECFF
4← crossover$16,023$576.45$16,585$967.82$562.00MRK
5$17,669$524.42$19,342$1,363.89$1.7KMRK
6$19,380$473.98$22,913$1,947.19$3.5KMRK
7$21,163$426.10$27,662$2,823.89$6.5KMRK
8$23,025$381.37$34,159$4,173.35$11.1KMRK
9$24,977$340.10$43,337$6,308.80$18.4KMRK
10$27,028$302.38$56,776$9,798.13$29.7KMRK

GECFF vs MRK: Complete Analysis 2026

GECFFStock

Gecina operates innovative and sustainable living spaces. The Group owns, manages and develops Europe's leading office portfolio, with nearly 97% located in the Paris Region, and a portfolio of residential assets and student residences, with over 9,000 apartments. These portfolios are valued at 20 billion euros at end-June 2020. Gecina has firmly established its focus on innovation and its human approach at the heart of its strategy to create value and deliver on its purpose: "Empowering shared human experiences at the heart of our sustainable spaces". For our 100,000 clients, this ambition is supported by our client-centric brand YouFirst. It is also positioned at the heart of UtilesEnsemble, our label setting out our commitment to the environment, to people and to the quality of life in cities. Gecina is a French real estate investment trust (SIIC) listed on Euronext Paris, and is part of the SBF 120, CAC Next 20, CAC Large 60, Euronext 100, FTSE4Good, DJSI Europe and World, Stoxx Global ESG Leaders and Vigeo indices. In 2020, Gecina was awarded the maximum A rating in the CDP climate change rankings.

Full GECFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GECFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GECFF vs SCHDGECFF vs JEPIGECFF vs OGECFF vs KOGECFF vs MAINGECFF vs JNJGECFF vs ABBVGECFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.